Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Surveys and Questionnaires × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Depression 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Support of the Family as a Caregiving System 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Peripheral Arterial Disease 1 Ovarian Neoplasms 1 Obesity 1 Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver 1 Neoplasms 1 Motor Activity 1 Melanoma 1 Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia 1 Laryngeal Diseases 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡